On the public citation graph

Mononuclear Cellular Infiltrates in Clinically Involved Skin from Patients with Systemic Sclerosis of Recent Onset Predominantly Consist of Monocytes/Macrophages

https://doi.org/10.1159/000163933
0 signed · 159 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4173719openalex-extracted
inferred← citeshttps://doi.org/10.1001/archderm.137.10.1309openalex-snapshot
Identification of Clonal T Cells in the Blood of Patients With Systemic Sclerosis
inferred← citeshttps://doi.org/10.1002/1529-0131(200011)43:11<2598::aid-anr30>3.0.co;2-8openalex-snapshot
Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride
inferred← citeshttps://doi.org/10.1002/9781118441213.rtd0057openalex-snapshot
Systemic Sclerosis (Systemic Scleroderma)
inferred← citeshttps://doi.org/10.1002/9781119709268.rook054openalex-snapshot
Systemic Sclerosis
inferred← citeshttps://doi.org/10.1002/art.10361openalex-snapshot
Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis
inferred← citeshttps://doi.org/10.1002/art.20315openalex-snapshot
Is systemic sclerosis an antigen‐driven T cell disease?
inferred← citeshttps://doi.org/10.1002/art.21646openalex-snapshot
DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti–topoisomerase I autoantibodies from systemic sclerosis patients
inferred← citeshttps://doi.org/10.1002/art.22877openalex-snapshot
T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro
inferred← citeshttps://doi.org/10.1002/art.24471openalex-snapshot
Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents
inferred← citeshttps://doi.org/10.1002/art.37706openalex-snapshot
Interleukin‐13–producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis
inferred← citeshttps://doi.org/10.1002/art.37712openalex-snapshot
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis
inferred← citeshttps://doi.org/10.1002/art.40243openalex-snapshot
Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum
inferred← citeshttps://doi.org/10.1002/art.41737openalex-snapshot
Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis
inferred← citeshttps://doi.org/10.1002/art.41813openalex-snapshot
Expansion of Fcγ Receptor IIIa –Positive Macrophages, Ficolin 1–Positive Monocyte‐Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis
inferred← citeshttps://doi.org/10.1007/978-1-4419-5774-0_15openalex-snapshot
Immunological Mechanisms
inferred← citeshttps://doi.org/10.1007/978-1-4419-5774-0_16openalex-snapshot
Innate Immunity
inferred← citeshttps://doi.org/10.1007/978-3-319-29785-9_32openalex-snapshot
Cutaneous Fibrosis and Normal Wound Healing
inferred← citeshttps://doi.org/10.1007/978-3-319-31407-5_13openalex-snapshot
Inflammation and Immunity
inferred← citeshttps://doi.org/10.1007/978-3-319-98143-7_3openalex-snapshot
Macrophage Plasticity in Skin Fibrosis
inferred← citeshttps://doi.org/10.1007/bf00870304openalex-snapshot
T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples
inferred← citeshttps://doi.org/10.1007/s001050050012openalex-snapshot
Mikrochimerismus
inferred← citeshttps://doi.org/10.1007/s00281-015-0504-6openalex-snapshot
Epigenetics and systemic sclerosis
inferred← citeshttps://doi.org/10.1007/s00281-015-0510-8openalex-snapshot
Fibrogenesis, novel lessons from animal models
inferred← citeshttps://doi.org/10.1007/s00281-015-0511-7openalex-snapshot
Cytokines in the immunopathology of systemic sclerosis
inferred← citeshttps://doi.org/10.1007/s002810000035openalex-snapshot
T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples
inferred← citeshttps://doi.org/10.1007/s00403-004-0472-5openalex-snapshot
Augmented production of transforming growth factor-β by cultured peripheral blood mononuclear cells from patients with systemic sclerosis
inferred← citeshttps://doi.org/10.1007/s00403-005-0635-zopenalex-snapshot
The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
inferred← citeshttps://doi.org/10.1007/s004030000134openalex-snapshot
Chemokine release from activated human dermal microvascular endothelial cells - implications for the pathophysiology of scleroderma?
inferred← citeshttps://doi.org/10.1007/s00425-025-04671-8openalex-snapshot
The regulatory role of phytohormones in plant drought tolerance
inferred← citeshttps://doi.org/10.1007/s11926-000-0025-7openalex-snapshot
The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide
inferred← citeshttps://doi.org/10.1007/s11926-008-0031-8openalex-snapshot
Circulating progenitor cells and scleroderma
inferred← citeshttps://doi.org/10.1007/s12016-017-8636-1openalex-snapshot
Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist’s, Clinician’s, and Patient’s Perspective
inferred← citeshttps://doi.org/10.1007/s12026-007-0044-9openalex-snapshot
Human autoimmune diseases are specific antigen-driven T-cell diseases: identification of the antigens
inferred← citeshttps://doi.org/10.1007/s12079-011-0131-5openalex-snapshot
Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?
inferred← citeshttps://doi.org/10.1016/b978-0-12-800957-4.00012-6openalex-snapshot
Epigenetics and Systemic Sclerosis
inferred← citeshttps://doi.org/10.1016/b978-0-323-85831-1.00022-xopenalex-snapshot
T cells in the pathogenesis of systemic sclerosis
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3285-4.10077-4openalex-snapshot
Systemic Sclerosis and the Scleroderma-Spectrum Disorders
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2016.12.001openalex-snapshot
Cellular and Molecular Mechanisms of Autoimmunity and Lupus Nephritis
inferred← citeshttps://doi.org/10.1016/j.ajpath.2025.09.009openalex-snapshot
Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model
inferred← citeshttps://doi.org/10.1016/j.autrev.2011.04.013openalex-snapshot
B cells in systemic sclerosis: A possible target for therapy
inferred← citeshttps://doi.org/10.1016/j.autrev.2013.04.004openalex-snapshot
Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of Systemic Sclerosis and Sjögren's Syndrome
inferred← citeshttps://doi.org/10.1016/j.autrev.2015.10.005openalex-snapshot
Systemic sclerosis: New evidence re-enforces the role of B cells
inferred← citeshttps://doi.org/10.1016/j.autrev.2021.102755openalex-snapshot
Mesenchymal stromal cells for systemic sclerosis treatment
inferred← citeshttps://doi.org/10.1016/j.autrev.2024.103540openalex-snapshot
What have we learned on pre, very early, and early systemic sclerosis microcirculatory pathophysiology? A scoping review
inferred← citeshttps://doi.org/10.1016/j.bcp.2005.11.018openalex-snapshot
Fibroblast heterogeneity in collagenolytic response to colchicine
inferred← citeshttps://doi.org/10.1016/j.berh.2022.101813openalex-snapshot
Novel therapies and innovation for systemic sclerosis skin ulceration
inferred← citeshttps://doi.org/10.1016/j.clindermatol.2024.12.007openalex-snapshot
Genetic and molecular drivers of scleroderma pathogenesis
inferred← citeshttps://doi.org/10.1016/j.febslet.2011.04.028openalex-snapshot
Toll‐like receptors in rheumatic diseases: Are we paying a high price for our defense against bugs?
inferred← citeshttps://doi.org/10.1016/j.hcl.2014.09.006openalex-snapshot
Connective Tissue Disorders Associated with Vasculitis and Vaso-Occlusive Disease of the Hand
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e16206openalex-snapshot
M2 macrophage polarization in systemic sclerosis fibrosis: pathogenic mechanisms and therapeutic effects
inferred← citeshttps://doi.org/10.1016/j.jaut.2020.102444openalex-snapshot
CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis
inferred← citeshttps://doi.org/10.1016/j.jaut.2020.102526openalex-snapshot
Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosis
inferred← citeshttps://doi.org/10.1016/j.jdermsci.2004.09.007openalex-snapshot
Degree of CD14 expression in melanoma infiltrating mononuclear phagocytes
inferred← citeshttps://doi.org/10.1016/j.jdermsci.2012.10.010openalex-snapshot
Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis
inferred← citeshttps://doi.org/10.1016/j.jdermsci.2017.07.001openalex-snapshot
Regulatory T cell deficient scurfy mice exhibit a Th2/M2-like inflammatory response in the skin
inferred← citeshttps://doi.org/10.1016/j.patbio.2015.03.003openalex-snapshot
Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis
inferred← citeshttps://doi.org/10.1016/j.rdc.2007.11.002openalex-snapshot
Fibrosis in Systemic Sclerosis
inferred← citeshttps://doi.org/10.1016/j.revmed.2007.09.020openalex-snapshot
Sclérodermie systémique : de la physiopathologie au traitement
inferred← citeshttps://doi.org/10.1016/j.revmed.2010.07.015openalex-snapshot
Cytokines et différenciation lymphocytaire T au cours de la sclérodermie systémique
inferred← citeshttps://doi.org/10.1016/j.semarthrit.2007.10.010openalex-snapshot
The Immunobiology of Systemic Sclerosis
inferred← citeshttps://doi.org/10.1016/s0755-4982(06)74924-7openalex-snapshot
Physiopathologie de la sclérodermie systémique: état des lieux sur une affection aux multiples facettes
inferred← citeshttps://doi.org/10.1016/s0889-857x(03)00018-8openalex-snapshot
Fibrosis in scleroderma
inferred← citeshttps://doi.org/10.1016/s0889-857x(05)70294-5openalex-snapshot
PATHOGENESIS OF SCLERODERMA
inferred← citeshttps://doi.org/10.1016/s0939-8600(00)80021-8openalex-snapshot
Cyclosporine A-induced autoimmunity: an animal model for human scleroderma
inferred← citeshttps://doi.org/10.1016/s1357-4310(98)01405-1openalex-snapshot
New perspectives on the etiology of systemic sclerosis
inferred← citeshttps://doi.org/10.1016/s1568-9972(03)00005-3openalex-snapshot
Systemic sclerosis: current views of its pathogenesis
inferred← citeshttps://doi.org/10.1016/s2255-5021(13)70007-5openalex-snapshot
Characteristics of NK cell activity in patients with systemic sclerosis
inferred← citeshttps://doi.org/10.1038/jid.2011.472openalex-snapshot
Intrinsic Gene Expression Subsets of Diffuse Cutaneous Systemic Sclerosis Are Stable in Serial Skin Biopsies
inferred← citeshttps://doi.org/10.1038/labinvest.3700654openalex-snapshot
The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses
inferred← citeshttps://doi.org/10.1038/s41420-022-01264-2openalex-snapshot
Mesenchymal stem cells alleviate systemic sclerosis by inhibiting the recruitment of pathogenic macrophages
inferred← citeshttps://doi.org/10.1038/srep43532openalex-snapshot
Meta-analysis of the changes of peripheral blood regulatory T cell to CD4+ T cell ratio in patients with systemic sclerosis
inferred← citeshttps://doi.org/10.1046/j.1365-2249.1998.00721.xopenalex-snapshot
Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers
inferred← citeshttps://doi.org/10.1056/nejmra0806188openalex-snapshot
Scleroderma
inferred← citeshttps://doi.org/10.1073/pnas.2306965120openalex-snapshot
IL-6 trans-signaling in a humanized mouse model of scleroderma
inferred← citeshttps://doi.org/10.1074/jbc.m113.545822openalex-snapshot
Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein
inferred← citeshttps://doi.org/10.1074/jbc.m116.752469openalex-snapshot
Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis
inferred← citeshttps://doi.org/10.1080/07853890601098152openalex-snapshot
Update on pathophysiology of scleroderma with special reference to immunoinflammatory events
inferred← citeshttps://doi.org/10.1080/17402520500303297openalex-snapshot
Polymorphism of the Fractalkine Receptor CX3CR1 and Systemic Sclerosis‐associated Pulmonary Arterial Hypertension
inferred← citeshttps://doi.org/10.1080/1744666x.2017.1263153openalex-snapshot
Use of biologics and other novel therapies for the treatment of systemic sclerosis
inferred← citeshttps://doi.org/10.1088/1758-5090/ad998copenalex-snapshot
Development of immunocompetent full thickness skin tissue constructs to model skin fibrosis for high-throughput drug screening
inferred← citeshttps://doi.org/10.1093/rheumatology/keac031openalex-snapshot
Dysregulation of the gene signature of effector regulatory T cells in the early phase of systemic sclerosis
inferred← citeshttps://doi.org/10.1093/rheumatology/keac489openalex-snapshot
Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis
inferred← citeshttps://doi.org/10.1093/rheumatology/keq062openalex-snapshot
Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases
inferred← citeshttps://doi.org/10.1097/01.tp.0000245080.71722.87openalex-snapshot
Predominant Infiltration of Monocytes in Chronic Graft-Versus-Host Disease
inferred← citeshttps://doi.org/10.1097/bor.0000000000000657openalex-snapshot
Macrophages and cadherins in fibrosis and systemic sclerosis
inferred← citeshttps://doi.org/10.1097/bor.0b013e32834b0dacopenalex-snapshot
An update on an immune system that goes awry in systemic sclerosis
inferred← citeshttps://doi.org/10.1097/prs.0000000000006291openalex-snapshot
Fat Grafting for the Treatment of Scleroderma
inferred← citeshttps://doi.org/10.1097/tp.0b013e3181f2c92bopenalex-snapshot
Effects of Pravastatin on Murine Chronic Graft-Versus-Host Disease
inferred← citeshttps://doi.org/10.1101/2022.01.26.477822openalex-snapshot
Mindin is essential for cutaneous fibrogenesis in a new mouse model of systemic sclerosis
inferred← citeshttps://doi.org/10.1111/eci.12776openalex-snapshot
The role of micro RNA ‐5196 in the pathogenesis of systemic sclerosis
inferred← citeshttps://doi.org/10.1111/j.0906-6705.2005.00280.xopenalex-snapshot
Cellular and molecular mechanisms of bleomycin‐induced murine scleroderma: current update and future perspective
inferred← citeshttps://doi.org/10.1111/j.1365-2249.2006.03041.xopenalex-snapshot
Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin
inferred← citeshttps://doi.org/10.1111/j.1365-2249.2010.04189.xopenalex-snapshot
Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma)
inferred← citeshttps://doi.org/10.1111/j.1600-0625.2008.00828.xopenalex-snapshot
Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma
inferred← citeshttps://doi.org/10.1126/sciimmunol.abq6691openalex-snapshot
Epiregulin is a dendritic cell–derived EGFR ligand that maintains skin and lung fibrosis
inferred← citeshttps://doi.org/10.1136/annrheumdis-2012-202814openalex-snapshot
Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin
inferred← citeshttps://doi.org/10.1136/annrheumdis-2013-204401openalex-snapshot
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
inferred← citeshttps://doi.org/10.1136/annrheumdis-2016-210189openalex-snapshot
Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages
inferred← citeshttps://doi.org/10.1136/annrheumdis-2018-214295openalex-snapshot
Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting
inferred← citeshttps://doi.org/10.1136/annrheumdis-2019-215119openalex-snapshot
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis
inferred← citeshttps://doi.org/10.1136/annrheumdis-2019-215894openalex-snapshot
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
inferred← citeshttps://doi.org/10.1136/ard.2003.018705openalex-snapshot
Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
inferred← citeshttps://doi.org/10.1136/ard.2004.030338openalex-snapshot
Up regulated expression of tumour necrosis factor α converting enzyme in peripheral monocytes of patients with early systemic sclerosis
inferred← citeshttps://doi.org/10.1136/ard.2008.096123openalex-snapshot
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
inferred← citeshttps://doi.org/10.1136/ard.2009.117119openalex-snapshot
What are the new milestones in the pathogenesis of systemic sclerosis?
inferred← citeshttps://doi.org/10.1136/ard.2010.134858openalex-snapshot
NFκB activation and stimulation of chemokine production in normal human macrophages by the gadolinium-based magnetic resonance contrast agent Omniscan: possible role in the pathogenesis of nephrogenic systemic fibrosis
inferred← citeshttps://doi.org/10.1136/jcp.2004.019224openalex-snapshot
Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1β, and tumour necrosis factor α in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis
inferred← citeshttps://doi.org/10.1155/2021/9920416openalex-snapshot
Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment
inferred← citeshttps://doi.org/10.1159/000094242openalex-snapshot
Chemokines and Chemokine Receptors in Scleroderma
inferred← citeshttps://doi.org/10.1177/0300985812450718openalex-snapshot
Immunophenotypical Characterization of Macrophages in Rat Bleomycin-Induced Scleroderma
inferred← citeshttps://doi.org/10.1177/2397198319838140openalex-snapshot
Fos-related antigen-1 transgenic mouse as a model for systemic sclerosis: A potential role of M2 polarization
inferred← citeshttps://doi.org/10.1186/ar3167openalex-snapshot
The cytokine language of monocytes and macrophages in systemic sclerosis
inferred← citeshttps://doi.org/10.1186/ar4251openalex-snapshot
Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop
inferred← citeshttps://doi.org/10.1186/s13075-018-1569-0openalex-snapshot
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression
inferred← citeshttps://doi.org/10.1186/s13148-023-01445-5openalex-snapshot
Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis
inferred← citeshttps://doi.org/10.1186/s41927-021-00212-4openalex-snapshot
Adult onset Still’s disease in a patient with scleroderma: case report
inferred← citeshttps://doi.org/10.1201/9781420040395-30openalex-snapshot
Vascular Manifestations of Progressive Systemic Sclerosis
inferred← citeshttps://doi.org/10.1201/9781420040395.ch22openalex-snapshot
Vascular Manifestations of Progressive Systemic Sclerosis
inferred← citeshttps://doi.org/10.1371/journal.pone.0002696openalex-snapshot
Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
inferred← citeshttps://doi.org/10.1371/journal.pone.0033508openalex-snapshot
Differentiation Potential of CD14+ Monocytes into Myofibroblasts in Patients with Systemic Sclerosis
inferred← citeshttps://doi.org/10.1371/journal.pone.0110820openalex-snapshot
Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis
inferred← citeshttps://doi.org/10.1371/journal.pone.0281881openalex-snapshot
Periostin—An inducer of pro-fibrotic phenotype in monocytes and monocyte-derived macrophages in systemic sclerosis
inferred← citeshttps://doi.org/10.1515/pterid-2016-0010openalex-snapshot
Dissecting the enigma of scleroderma: possible involvement of the kynurenine pathway
inferred← citeshttps://doi.org/10.1517/13543784.12.3.471openalex-snapshot
Treatment of scleroderma: an update
inferred← citeshttps://doi.org/10.1586/eci.11.28openalex-snapshot
CD4+CD25+regulatory T cells in systemic sclerosis and other rheumatic diseases
inferred← citeshttps://doi.org/10.1590/s0482-50042013000100007openalex-snapshot
Características de atividade das células natural killer em pacientes com esclerose sistêmica
inferred← citeshttps://doi.org/10.2147/cbf.s60446openalex-snapshot
Biomarker discovery in systemic sclerosis: state of the art
inferred← citeshttps://doi.org/10.2147/ccid.s160923openalex-snapshot
Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast
inferred← citeshttps://doi.org/10.2174/0929867322666150209161224openalex-snapshot
Molecular and Cellular Pathways as Treatment Targets for Biologic Therapies in Systemic Sclerosis
inferred← citeshttps://doi.org/10.2174/1876539401003010037openalex-snapshot
Antigen-Presenting Cells and their Fcγ and Toll-Like Receptors: Leading Suspects in Autoimmunity
inferred← citeshttps://doi.org/10.2217/bmm.09.79openalex-snapshot
Biomarkers in Systemic Sclerosis
inferred← citeshttps://doi.org/10.2478/v10039-012-0076-9openalex-snapshot
Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis
inferred← citeshttps://doi.org/10.2741/2875openalex-snapshot
Pathogenic role of CCL2/MCP-1 in scleroderma
inferred← citeshttps://doi.org/10.3109/9780203490884-49openalex-snapshot
Spontaneous Canine Model of Alopecia Areata
inferred← citeshttps://doi.org/10.33590/emjrheumatol/10312451openalex-snapshot
Innate Immunity in Systemic Sclerosis – Role of Toll-Like Receptors, Interferon, and the Potential Impact of Vitamin D
inferred← citeshttps://doi.org/10.3389/fimmu.2013.00266openalex-snapshot
The Role of Type 1 Interferon in Systemic Sclerosis
inferred← citeshttps://doi.org/10.3389/fimmu.2018.00298openalex-snapshot
The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders
inferred← citeshttps://doi.org/10.3389/fimmu.2018.01702openalex-snapshot
Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1080310openalex-snapshot
Macrophage: Key player in the pathogenesis of autoimmune diseases
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1551911openalex-snapshot
A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways
inferred← citeshttps://doi.org/10.3389/fmicb.2022.860024openalex-snapshot
A U-Box Type E3 Ubiquitin Ligase Prp19-Like Protein Negatively Regulates Lipid Accumulation and Cell Size in Chlamydomonas reinhardtii
inferred← citeshttps://doi.org/10.3390/cells11233912openalex-snapshot
Hematopoietic Cell Transplantation for Systemic Sclerosis—A Review
inferred← citeshttps://doi.org/10.3390/ijms22052765openalex-snapshot
Butyrate Improves Skin/Lung Fibrosis and Intestinal Dysbiosis in Bleomycin-Induced Mouse Models
inferred← citeshttps://doi.org/10.3390/ijms22094365openalex-snapshot
Characterization of Long Non-Coding RNAs in Systemic Sclerosis Monocytes: A Potential Role for PSMB8-AS1 in Altered Cytokine Secretion
inferred← citeshttps://doi.org/10.4049/jimmunol.163.10.5693openalex-snapshot
Anti-TGF-β Treatment Prevents Skin and Lung Fibrosis in Murine Sclerodermatous Graft-Versus-Host Disease: A Model for Human Scleroderma
inferred← citeshttps://doi.org/10.4049/jimmunol.168.6.3088openalex-snapshot
Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation
inferred← citeshttps://doi.org/10.4049/jimmunol.168.7.3649openalex-snapshot
Oligoclonal T Cell Expansion in the Skin of Patients with Systemic Sclerosis
inferred← citeshttps://doi.org/10.4049/jimmunol.1801209openalex-snapshot
Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis
inferred← citeshttps://doi.org/10.4161/cc.10.13.16227openalex-snapshot
Scleroderma-like properties of skin from caveolin-1-deficient mice
inferred← citeshttps://doi.org/10.5152/eurjrheum.2016.15088openalex-snapshot
Serum Soluble CD163 and its association with various disease parameters in patients with systemic sclerosis
inferred← citeshttps://doi.org/10.5301/jsrd.5000226openalex-snapshot
Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview
inferred← citeshttps://doi.org/10.55563/clinexprheumatol/7ulgbjopenalex-snapshot
Implications of endothelial shear stress on systemic sclerosis vasculopathy and treatment
inferred← citeshttps://doi.org/10.6084/m9.figshare.26569522openalex-snapshot
Additional file 1 of Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis
inferred← citeshttps://doi.org/10.70675/71446f40z049cz46e8z8ec5zabcb6c311248openalex-snapshot
Altérations de l’efferocytose des macrophages induits par les cellules endothéliales : analyse des mécanismes et approche thérapeutique pour corriger la vasculopathie et la fibrose au cours de la sclérodermie systémique
inferred← citeshttps://doi.org/10.70675/917579acze581z4bfbzb10czc6d5c3150e9dopenalex-snapshot
Développement d'un médicament de thérapie innovante utilisant la fraction vasculaire stromale du tissu adipeux autologue dans la sclérodermie systémique : de la caractérisation biologique à l'identification de biomarqueurs potentiels d'efficacité
inferred← citeshttps://doi.org/10.70675/c232df01zeed2z45dfz87aczfcb8765fa15copenalex-snapshot
Propriétés angiogéniques et antifibrotiques des cellules progénitrices de la fraction vasculaire stromale du tissu adipeux dans la sclérodermie systémique
inferred← citeshttps://doi.org/10.70675/dfc4dd10z9fb4z4e16z836dz778a7ef9d1c1openalex-snapshot
«Trained immunity» et rôle de la mémoire macrophagique dans l'immunomodulation des maladies fibro-inflammatoires
inferred← citeshttps://doi.org/10.7326/0003-4819-140-1-200401060-00010openalex-snapshot
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.